CiteULike: xtizon's Brasch:RC [13 articles]

Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.

Radiology, Vol. 247, No. 2. (May 2008), pp. 391-399.

by H. J. Raatschen, G. H. Simon, Y. Fu, et al.B. Sennino, D. M. Shames, M. F. Wendland, D. M. McDonald, R. C. Brasch

posted to angiogenesis antiangiogenic mri permeability predictive animal-models by xtizon on 2009-04-08 21:50:54 as

Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns

Journal of Magnetic Resonance Imaging, Vol. 4, No. 3. (1994), pp. 381-388.

by Vladimir S. Vexler, Olivier Clément, Heribert Schmitt-Willich, Robert C. Brasch

posted to contrast-agent mri pharmaco-kinetic by xtizon on 2009-04-03 17:15:03 as

A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution

Magnetic Resonance in Medicine, Vol. 37, No. 2. (1997), pp. 236-242.

by Franci Demsar, Timothy P. L. Roberts, Heidi C. Schwickert, et al.David M. Shames, Cornelis F. Van Dijke, Jeffry S. Mann, Maythem Saeed, Robert C. Brasch

posted to angiogenesis contrast-agent macromolecular permeability tumor vasculature by xtizon on 2009-03-30 13:03:25 as

Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme

Journal of Magnetic Resonance Imaging, Vol. 15, No. 3. (2002), pp. 233-240.

by Axel Gossmann, Thomas H. Helbich, Nagato Kuriyama, et al.S. Ostrowitzki, Timothy P. L. Roberts, David M. Shames, N. van Bruggen, Michael F. Wendland, Mark A. Israel, Robert C. Brasch

posted to dce-mri glioma u87mg by xtizon on 2009-01-09 16:11:57 as

New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues

Journal of Magnetic Resonance Imaging, Vol. 27, No. 3. (2008), pp. 581-589.

by Clemens C. Cyran, Yanjun Fu, Hans-Juergen Raatschen, et al.Victor Rogut, Bundit Chaopathomkul, David M. Shames, Michael F. Wendland, Benjamin M. Yeh, Robert C. Brasch

posted to cancer contrast-agent dce-mri by xtizon on 2008-03-02 17:18:19 as

AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.

Magn Reson Imaging, Vol. 25, No. 3. (April 2007), pp. 319-327.

by L. J. Wilmes, M. G. Pallavicini, L. M. Fleming, et al.J. Gibbs, D. Wang, K. L. Li, S. C. Partridge, R. G. Henry, D. R. Shalinsky, D. Hu-Lowe, J. W. Park, T. M. McShane, Y. Lu, R. C. Brasch, N. M. Hylton

posted to breast dce-mri animal-models by xtizon on 2007-07-26 13:44:51 as

along with 1 person claudiacalcagno

A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution.

Magn Reson Med, Vol. 37, No. 2. (February 1997), pp. 236-242.

by F. Demsar, T. P. Roberts, H. C. Schwickert, et al.D. M. Shames, C. F. van Dijke, J. S. Mann, M. Saeed, R. C. Brasch

posted to contrast-agent dce-mri macromolecular by xtizon on 2007-07-23 13:43:57 as

Prostate Cancer Tumor Grade Differentiation with Dynamic Contrast-enhanced MR Imaging in the Rat: Comparison of Macromolecular and Small-Molecular Contrast Media-Preliminary Experience

Radiology, Vol. 213, No. 1. (1 October 1999), pp. 265-272.

by Axel Gossmann, Yoshitaka Okuhata, David M. Shames, et al.Thomas H. Helbich, Timothy P. Roberts, Michael F. Wendland, Sabine Huber, Robert C. Brasch

posted to dce-mri macromolecular prostate by xtizon on 2007-07-23 13:40:36 as

Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.

AJR Am J Roentgenol, Vol. 171, No. 4. (October 1998), pp. 941-949.

by H. Daldrup, D. M. Shames, M. Wendland, et al.Y. Okuhata, T. M. Link, W. Rosenau, Y. Lu, R. C. Brasch

posted to dce-mri macromolecular by xtizon on 2007-07-23 13:37:10 as

MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer.

J Magn Reson Imaging, Vol. 20, No. 5. (November 2004), pp. 865-873.

by A. Preda, V. Novikov, M. Möglich, et al.K. Turetschek, D. M. Shames, R. C. Brasch, F. M. Cavagna, T. P. Roberts

posted to mri avastin angiogenesis by xtizon on 2007-01-10 08:26:18 as

MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model.

Eur J Nucl Med Mol Imaging, Vol. 30, No. 3. (March 2003), pp. 448-455.

by K. Turetschek, A. Preda, E. Floyd, et al.D. M. Shames, V. Novikov, T. P. Roberts, J. M. Wood, Y. Fu, W. O. Carter, R. C. Brasch

posted to mri breast angiogenesis by xtizon on 2007-01-10 08:25:53 as

Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns.

J Magn Reson Imaging, Vol. 4, No. 3. (n 1994), pp. 381-388.

by V. S. Vexler, O. Clément, H. Schmitt-Willich, R. C. Brasch

posted to contrast-agent by xtizon on 2006-11-13 12:14:59 as

Tumor microvascular changes in antiangiogenic treatment: Assessment by magnetic resonance contrast media of different molecular weights

Journal of Magnetic Resonance Imaging, Vol. 20, No. 1. (2004), pp. 138-144.

by Karl Turetschek, Anda Preda, Viktor Novikov, et al.Robert C. Brasch, Hanns J. Weinmann, Patrick Wunderbaldinger, Timothy P. L. Roberts

posted to dce-mri mri perfusion syn_ai_042009 by xtizon on 2006-06-26 15:50:40 as

	Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats. [My Copy] Radiology, Vol. 247, No. 2. (May 2008), pp. 391-399. by H. J. Raatschen, G. H. Simon, Y. Fu, et al.B. Sennino, D. M. Shames, M. F. Wendland, D. M. McDonald, R. C. Brasch posted to angiogenesis antiangiogenic mri permeability predictive animal-models by xtizon on 2009-04-08 21:50:54 as
	Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns [My Copy] Journal of Magnetic Resonance Imaging, Vol. 4, No. 3. (1994), pp. 381-388. by Vladimir S. Vexler, Olivier Clément, Heribert Schmitt-Willich, Robert C. Brasch posted to contrast-agent mri pharmaco-kinetic by xtizon on 2009-04-03 17:15:03 as
	A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution [My Copy] Magnetic Resonance in Medicine, Vol. 37, No. 2. (1997), pp. 236-242. by Franci Demsar, Timothy P. L. Roberts, Heidi C. Schwickert, et al.David M. Shames, Cornelis F. Van Dijke, Jeffry S. Mann, Maythem Saeed, Robert C. Brasch posted to angiogenesis contrast-agent macromolecular permeability tumor vasculature by xtizon on 2009-03-30 13:03:25 as
	Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme [My Copy] Journal of Magnetic Resonance Imaging, Vol. 15, No. 3. (2002), pp. 233-240. by Axel Gossmann, Thomas H. Helbich, Nagato Kuriyama, et al.S. Ostrowitzki, Timothy P. L. Roberts, David M. Shames, N. van Bruggen, Michael F. Wendland, Mark A. Israel, Robert C. Brasch posted to dce-mri glioma u87mg by xtizon on 2009-01-09 16:11:57 as
	New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues [My Copy] Journal of Magnetic Resonance Imaging, Vol. 27, No. 3. (2008), pp. 581-589. by Clemens C. Cyran, Yanjun Fu, Hans-Juergen Raatschen, et al.Victor Rogut, Bundit Chaopathomkul, David M. Shames, Michael F. Wendland, Benjamin M. Yeh, Robert C. Brasch posted to cancer contrast-agent dce-mri by xtizon on 2008-03-02 17:18:19 as
	AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. [My Copy] Magn Reson Imaging, Vol. 25, No. 3. (April 2007), pp. 319-327. by L. J. Wilmes, M. G. Pallavicini, L. M. Fleming, et al.J. Gibbs, D. Wang, K. L. Li, S. C. Partridge, R. G. Henry, D. R. Shalinsky, D. Hu-Lowe, J. W. Park, T. M. McShane, Y. Lu, R. C. Brasch, N. M. Hylton posted to breast dce-mri animal-models by xtizon on 2007-07-26 13:44:51 as along with 1 person claudiacalcagno
	A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution. [My Copy] Magn Reson Med, Vol. 37, No. 2. (February 1997), pp. 236-242. by F. Demsar, T. P. Roberts, H. C. Schwickert, et al.D. M. Shames, C. F. van Dijke, J. S. Mann, M. Saeed, R. C. Brasch posted to contrast-agent dce-mri macromolecular by xtizon on 2007-07-23 13:43:57 as
	Prostate Cancer Tumor Grade Differentiation with Dynamic Contrast-enhanced MR Imaging in the Rat: Comparison of Macromolecular and Small-Molecular Contrast Media-Preliminary Experience [My Copy] Radiology, Vol. 213, No. 1. (1 October 1999), pp. 265-272. by Axel Gossmann, Yoshitaka Okuhata, David M. Shames, et al.Thomas H. Helbich, Timothy P. Roberts, Michael F. Wendland, Sabine Huber, Robert C. Brasch posted to dce-mri macromolecular prostate by xtizon on 2007-07-23 13:40:36 as
	Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. [My Copy] AJR Am J Roentgenol, Vol. 171, No. 4. (October 1998), pp. 941-949. by H. Daldrup, D. M. Shames, M. Wendland, et al.Y. Okuhata, T. M. Link, W. Rosenau, Y. Lu, R. C. Brasch posted to dce-mri macromolecular by xtizon on 2007-07-23 13:37:10 as
	MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer. [My Copy] J Magn Reson Imaging, Vol. 20, No. 5. (November 2004), pp. 865-873. by A. Preda, V. Novikov, M. Möglich, et al.K. Turetschek, D. M. Shames, R. C. Brasch, F. M. Cavagna, T. P. Roberts posted to mri avastin angiogenesis by xtizon on 2007-01-10 08:26:18 as
	MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model. [My Copy] Eur J Nucl Med Mol Imaging, Vol. 30, No. 3. (March 2003), pp. 448-455. by K. Turetschek, A. Preda, E. Floyd, et al.D. M. Shames, V. Novikov, T. P. Roberts, J. M. Wood, Y. Fu, W. O. Carter, R. C. Brasch posted to mri breast angiogenesis by xtizon on 2007-01-10 08:25:53 as
	Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns. [My Copy] J Magn Reson Imaging, Vol. 4, No. 3. (n 1994), pp. 381-388. by V. S. Vexler, O. Clément, H. Schmitt-Willich, R. C. Brasch posted to contrast-agent by xtizon on 2006-11-13 12:14:59 as
	Tumor microvascular changes in antiangiogenic treatment: Assessment by magnetic resonance contrast media of different molecular weights [My Copy] Journal of Magnetic Resonance Imaging, Vol. 20, No. 1. (2004), pp. 138-144. by Karl Turetschek, Anda Preda, Viktor Novikov, et al.Robert C. Brasch, Hanns J. Weinmann, Patrick Wunderbaldinger, Timothy P. L. Roberts posted to dce-mri mri perfusion syn_ai_042009 by xtizon on 2006-06-26 15:50:40 as

xtizon's Brasch:RC [13 articles] Export

xtizon's tags

bibtex-import	529
mri	323
cancer	248
dce-mri	207
review	194
medical-imaging	91
segmentation	84
brain	84
angiogenesis	79
dw-mri	62
tumor	59
pet	58
prostate	55
angiography	52
imaging	52
image-analysis	44
antiangiogenic	40
vessel	37
contrast-agent	34
breast	33
methodology	33
uspio	33
glioma	31
measurement	30
registration	29
animal-models	25
perfusion	25
response	23
biomarker	23
modelization	22
mrs	22
biology	22
spectroscopy	22
clustering	20
rodent	19
molecular-imaging	18
artifacts	18
model	18
level-sets	17
3d	17
macrophages	17
pattern-recognition	17
metastasis	15
correction	14
vegf	14
statistics	14
vasculature	14
analysis	14
radiotherapy	13
dimensionnality-reduction	13
atherosclerosis	13
pdf	13
image-processing	13
classification	12
apoptosis	12
hypoxia	12
liver	12
lung	12
macromolecular	12
chemotherapy	11
sinerem	11
vsi	11
syn_ai_042009	11
diffusion	11
human	11
vascularization	11
active-contours	10
similarity	10
mr-spectro	10
ct	10
shape	10
oncology	10
quality	10
visualization	9
mutual-information	9
treatment	9
bold	9
mouse	9
contrast-enhanced	8
deconvolution	8
adc	8
coronary	8
fuzzy	8
antivascular	8
noise	8
fdg	8
arterial-input-function	8
inflammation	7
apparent-diffusion-coefficient	7
pancreas	7
distance	7
geometry	7
texture	7
t1	7
spect	7
histology	7
diagnosis	6
reconstruction	6
choline	6
oxygenation	6
microenvironment	6
ultrasound	6
enhancement	6
theory	6
region-growing	6
ica	6
drug	5
mathematical-morphology	5
physics	5
t2	5
carotid	5
kidney	5
drug-development	5
snakes	5
mathematics	5
small-animal	5
artefacts	5
mean-shift	5
fuzzy-connectedness	5
pharmaco-kinetic	5
vascular-normalization	5
graph	5
gd-dtpa	5
transcytolemmal-water-exchange	5
validity	5
combination	5
suv	5
dsc-mri	5
models	5
tortuosity	5
denoising	5
pve	5
resistance	5
algorithm	5
mra	4
clinical-trial	4
bladder	4
skeletonization	4
svm	4
whole-body	4
pet-ct	4
irm	4
vta	4
pharmacology	4
microscopy	4
xenograft	4
permeability	4
cytotoxic	4
software	4
cardiac	4
multimodality	4
rat	4
kappa	4
validation	4
reference	4
reproducibility	4
scale-space	4
post-processing	4
toget	4
blood-volume	3
epi	3
quantification	3
spectral-clustering	3
ktrans	3
nanoparticles	3
roi	3
pet-mr	3
dwi	3
snr	3
heart	3
immunohistochemistry	3
robust	3
flow	3
scale	3
measure	3
proliferation	3
pca	3
molecular	3
video	3
necrosis	3
colon	3
cell-traficking	3
t1rho	3
evaluation	3
colorectal	3
filtering	3
connectedness	3
bayesian	3
france	3
susceptibility	3
fmri	3
pk-pd	3
vascularity	3
psa	3
temozolomide	3
spio	3
cardiovascular	3
compressed-sensing	2
lymphoma	2
multiscale	2
phantom	2
quality-control	2
blood-pool-ca	2
metronomic-schedule	2
deformation	2
edge	2
risk	2
em	2
french	2
image-quality	2
inhomogeneity	2
distortion	2
ifp	2
pressure	2
emd	2
histogram	2
random-walks	2
fourier	2
thresholding	2
calibration	2
sunitinib	2
avastin	2
distribution	2
pk	2
citrate	2
size	2
topology	2
symmetry	2
anesthesia	2
feature	2
imaginary	2
minimum-cost	2
arterial-spin-labeling	2
lle	2
paclitaxel	2
predictive	2
blind	2
temperature	2
subcutaneaous	2
standard	2
field-inhomogeneity	2
cell	2
xray	2
flt-pet	2
optimization	2
graph-theory	2
number-clusters	2
scientific-writing	2
bevacizumab	2
oxygen	2
sorafenib	2
nuclear-medicine	2
perso	2
therapy	2
shortest-path	2
fat	2
tomography	2
cancer-stem-cells	2
breathing	2
gleason	2
magnetic-field	2
relaxation	2
anisotropic-diffusion	2
glucarate	2
contrast	2
mr-physics	2
spline	2
science	2
muscle	2
small-samples	2
research	2
asm	2
anapath	2
wavelets	2
gadolinium	2
entropy	2
kinase	1
u87mg	1
thorax	1
objective	1
matlab	1
p53	1
binary	1
spleen	1
radiation	1
positive-contrast	1
integrin	1
open-source	1
relaxivity	1
motion-correction	1
matching	1
medial-axis	1
information-theory	1
rodents	1
k-means	1
nephrogenic-systemic-fibrosis	1
sem	1
tool	1
deformable-models	1
shape-gradient	1
mip	1
echography	1
rectal	1
factor-analysis	1
axis	1
intravital-microscopy	1
least-squares	1
fluorocholine	1
laplacian-eigenmaps	1
watershed	1
filter	1
blood-flow	1
phase	1
minimum-length-description	1
centerline	1
technology	1
discrete	1
expectation-maximization	1
gradient	1
fusion	1
pharmaco-dynamic	1
p760	1
sparse	1
automatic-differentiation	1
nonlinear	1
diameter	1
heterogeneity	1
moments	1
vitro	1
estimation	1
deuterium	1
inpainting	1
database	1
volume	1
taurine	1
staging	1
reaction-diffusion	1
medical	1
ridgelet	1
tumors	1
flood	1
stroma	1
stenosis	1
morphology	1
aneurysm	1
manifold	1
wiki	1
fast-marching	1
physical-information	1
industry	1
std	1
multispectral	1
cytokines	1
cardiovscular	1
sw-mri	1
gaussian	1
midllemolecular	1
dynamic	1
multicenter	1
blood	1
bias	1
roc	1
in-vitro	1
k-nn	1
oxygena	1
attenuation-correction	1
random-fields	1
uppsala	1
lungs	1
arteries-veins-separation	1
tubingen	1
hr-mas	1
shutter-speed	1
escape	1
toxicity	1
connectivity	1
connected-component	1
normalized-cuts	1
adipose_tissue	1
flt	1
blog	1
distance-transform	1
quantitative-imaging	1
ecst	1
autoradiography	1
embedding	1
geography	1
complexity	1
fisher-information	1
insilico	1
curvature	1
euclidean-distance-transform	1
dab	1
orientation	1
swi	1
nascet	1
pde	1
recognition	1
tissue-microarray	1
gene	1
ischemia	1
mtor	1
color	1
gadomer	1
transgenic	1
projection	1
application	1
lcmodel	1
spectral-segmentation	1
fourier-descriptors	1
microarray	1
blur	1
parametric	1
network	1
dexamethasone	1
bilateral-filtering	1
waveletes	1
glioblastoma	1
descriptors	1
perspective	1
atlas	1
2d	1
risk-factor	1
t2w	1
focus	1
corner	1
phenotyping	1
3t	1
erlotinib	1
fluorothymidine	1
pathway	1
subspace	1
haussdorf	1
bioinformatics	1
systems-biology	1
bioluminescence	1
translation	1
alzheimer	1
fcm	1
ub	1
gene-expression	1
markov-models	1
fingerprint	1
rcbv	1
consensus	1
k-space	1
fmiso	1
eikonal	1
imrt	1
hahn	1
optical-imaging	1
blob	1
boosting	1
encoding	1
ontology	1
genetic_algorithms	1
in-silico-drug-development	1
graph-cut	1
survey	1
pd	1
activity	1
learning	1
livewire	1
rcc	1
immunology	1
optical	1
dti	1
nonlocal	1
reivew	1
interpolation	1
lda	1
vector-quantification	1
recist	1
tracking	1
genetics	1
writing	1
le2i	1
animage	1
inria	1
fitting	1
personalized-medicine	1
4d	1
nuclear-imaging	1
ift	1
fluorescence-microscopy	1
biodistribution	1
r2star	1
cbv	1
edt	1
nanoparticle	1
p792	1
murine	1
fractal	1
gefitinib	1
vascular-disrupting-agent	1
docetaxel	1
rnai	1
rgd	1
emddistance	1